Ciena Corporation vs. DNA X, Inc. Common Stock
DNA X, Inc. Common Stock (SONM) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| CIEN | SONM | |
|---|---|---|
| Market Cap | $49.46 billion | $4.49 million |
| Revenue (TTM) | $6.02 billion | $-27,911,000 |
| Net Income (TTM) | $654.41 million | $-8,547,000 |
CIEN leads on 3 of 3 size & scale factors.
Valuation
| CIEN | SONM | |
|---|---|---|
| P/E Ratio | 78.03 | — |
| Price / Book | 16.18 | -3.65 |
| Price / Sales | 8.22 | -0.16 |
SONM leads on 2 of 2 valuation factors.
Profitability
| CIEN | SONM | |
|---|---|---|
| Net Margin | 10.87% | 30.62% |
| Return on Equity | 21.41% | 693.75% |
SONM leads on 2 of 2 profitability factors.
Risk & Sentiment
| CIEN | SONM | |
|---|---|---|
| Short Interest | 12.07% | 0.85% |
SONM leads on 1 of 1 risk & sentiment factors.
Dig deeper: CIEN overview, CIEN financials, SONM overview, SONM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.